Apollo Medical Holdings Inc
NASDAQ:ASTH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
32.96
62.54
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Apollo Medical Holdings Inc
Apollo Medical Holdings Inc
Net Issuance of Common Stock
Apollo Medical Holdings Inc
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Apollo Medical Holdings Inc
NASDAQ:ASTH
|
Net Issuance of Common Stock
-$8.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Net Issuance of Common Stock
-$1.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Issuance of Common Stock
-$211m
|
CAGR 3-Years
53%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-22%
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Issuance of Common Stock
-$2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Cigna Corp
NYSE:CI
|
Net Issuance of Common Stock
-$5.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Issuance of Common Stock
-$113m
|
CAGR 3-Years
43%
|
CAGR 5-Years
31%
|
CAGR 10-Years
11%
|
|
Apollo Medical Holdings Inc
Glance View
Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,133 full-time employees. The firm through its subsidiary provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company operates an integrated healthcare delivery platform that enables providers to participate in value-based care arrangements. To implement a patient-centered, physician-centric experience, the Company has other integrated and synergistic operations, including management service organizations (MSOs) that provide management and other services to its affiliated independent practice associations (IPAs), outpatient clinics, and hospitalists that coordinates the care of patients in hospitals.
See Also
What is Apollo Medical Holdings Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
-8.7m
USD
Based on the financial report for Dec 31, 2023, Apollo Medical Holdings Inc's Net Issuance of Common Stock amounts to -8.7m USD.
What is Apollo Medical Holdings Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 1Y
-1 305%
Over the last year, the Net Issuance of Common Stock growth was -1 305%.
You don't have any saved screeners yet
